CD19-Directed CAR T-Cells Yielded High CR Rates in Relapsed, Refractory Follicular Lymphoma

Leggi l'articolo originale


A new study looked at the rates of response and remission in patients with relapsed or refractory follicular lymphoma  who underwent CD19-directed CAR-T cell therapy.

Lascia un commento